Structural Aspects of the p53 Protein in Relation to Gene Evolution: A Second Look
The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
Several years ago, a comparison of the amino acid sequences of p53 proteins from a variety of species enabled us to reveal structural features of this protein, giving clues to its function. Since then, numerous studies on the biochemical, immunological and biological functions of p53 as well as on its structure (including crystallography data) have provided considerable insight into the multifunctional aspects of p53. The purpose of this review is to present the most recent data concerning the various structural features of the p53 protein with special emphasis on its flexibility, which plays a key role in regulation of its biological activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321 · cited 2×
“…a 21 kDa protein that specifically inhibits the kinase activity of the cdk2-cyclin complex required for the G1 to S transition of the cell-cycle (El-Deiry et al., 1993); the IGF-BP3 gene, which is also a negative regulator of cell proliferation (Buckbinder et al., 1995); the GADD45 gene, which…”
BackgroundParticipation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 4,296
Tumor suppressor p53 is a direct transcriptional activator of the human bax gene
Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063 · cited 1×
“…that binds to PCNA (Smith et al., 1994) but with a controversial role in DNA repair (Kazantsev & Sancar, 1995; Kearsey et al., 1995); the Bax gene (Miyashita & Reed, 1995), whose product is involved in the regulation of 0022–2836/96/300623–15 $18.00/0 7 apoptosis ; and the mdm2 gene , which…”
BackgroundInfluentialMutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,961
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 4×
“This hypothesis has been confirmed by crystallographic data (Cho et al., 1994).”
BackgroundInfluentialDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
Oliner, J. D., Pietenpol, J. A., Thiagalingam, S., Gyuris, J., Kinzler, K. W., & Vogelstein, B. (1993) · Nature · doi:10.1038/362857a0 · Cited by 1,451
Finlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
The structure and function of proline-rich regions in proteins
Williamson, M. P. (1994) · Biochemical Journal · doi:10.1042/bj2970249 · Cited by 1,005
Cited by
p53 and Human Cancer: The First Ten Thousand Mutations
(1999) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60785-x · Cited by 986
Stommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
“This sequence is highly conserved in widely divergent species, and in the recently discovered p53 homologues p51, p63 and p73 (Figure 1A; Soussi and May, 1996; Cheng et al., 1997; Kaghad et al., 1997; Osada et al., 1998; Yang et al., 1998).”
BackgroundTwenty years of p53 research: structural and functional aspects of the p53 protein
May, P., & May, E. (1999) · Oncogene · doi:10.1038/sj.onc.1203285 · Cited by 663
Self-citationMDM2 — master regulator of the p53 tumor suppressor protein
Momand, J., Wu, H.-H., & Dasgupta, G. (2000) · Gene · doi:10.1016/s0378-1119(99)00487-4 · Cited by 641
Drosophila p53 Binds a Damage Response Element at the reaper Locus
Brodsky, M. H., Nordstrom, W., Tsang, G., Kwan, E., Rubin, G. M., & Abrams, J. M. (2000) · Cell · doi:10.1016/s0092-8674(00)80627-3 · Cited by 473
ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins
Waterman, M. J. F., Stavridi, E. S., Waterman, J. L. F., & Halazonetis, T. D. (1998) · Nature Genetics · doi:10.1038/542 · Cited by 460
Bullock, A. N., Henckel, J., & Fersht, A. R. (2000) · Oncogene · doi:10.1038/sj.onc.1203434 · Cited by 434
Protein‐misfolding diseases and chaperone‐based therapeutic approaches
Chaudhuri, T. K., & Paul, S. (2006) · The FEBS Journal · doi:10.1111/j.1742-4658.2006.05181.x · Cited by 419
The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis
Schumacher, B., Hofmann, K., Boulton, S., & Gartner, A. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00534-6 · Cited by 360
Electrochemical biosensors for DNA hybridization and DNA damage
Paleček, E., Fojta, M., Tomschik, M., & Wang, J. (1998) · Biosensors and Bioelectronics · doi:10.1016/s0956-5663(98)00017-7 · Cited by 294
Reles, A., Wen, W., Schmider, A., Gee, C., Runnebaum, I. B., Kilian, U., Jones, L. A., El‐Naggar, A. K., Minguillon, C., Schönborn, I., et al. (2001) · PubMed · Cited by 282
How p53 binds DNA as a tetramer
McLure, K. G., & Lee, P. W. K. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3342 · Cited by 260
“Mutations in the p53 DNA-binding domain probably contribute to tumorigenesis due to the requirement for DNA binding of p53 tumor suppressor activity (reviewed by Ko and Prives, 1996; Soussi and May, 1996; Levine, 1997).”
BackgroundPhosphorylation of Serine 392 Stabilizes the Tetramer Formation of Tumor Suppressor Protein p53
Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E., & Xie, D. (1997) · Biochemistry · doi:10.1021/bi970759w · Cited by 246
Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability
Nikolova, P. V., Henckel, J., Lane, D. P., & Fersht, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14675 · Cited by 240
The N-terminal Domain of p53 is Natively Unfolded
Dawson, R., Müller, L., Dehner, A., Klein, C., Kessler, H., & Buchner, J. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.008 · Cited by 229
Multisite Phosphorylation and the Integration of Stress Signals at p53
Meek, D. W. (1998) · Cellular Signalling · doi:10.1016/s0898-6568(97)00119-8 · Cited by 185
Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations
Nikolova, P. V., Wong, K., DeDecker, B., Henckel, J., & Fersht, A. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.370 · Cited by 152
Involvement of p53 in cell differentiation and development
Almog, N., & Rotter, V. (1997) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(97)00012-7 · Cited by 162
The UMD-p53 database: New mutations and analysis tools
Béroud, C., & Soussi, T. (2003) · Human Mutation · doi:10.1002/humu.10187 · Cited by 155
Self-citationCraig, A. L., Burch, L. R., VOJTESEK, B., MIKUTOWSKA, J., Thompson, A. M., & Hupp, T. R. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3420133 · Cited by 147
Mateu, M. G., & Fersht, A. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.10.2748 · Cited by 169
Campomenosi, P., Monti, P., Aprile, A., Abbondandolo, A., Frébourg, T., Gold, B. I., Crook, T., Inga, A., Resnick, M. A., Iggo, R. D., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204468 · Cited by 150
Covalent and noncovalent modifiers of the p53 protein
Jayaraman, L., & Prives, C. L. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050271 · Cited by 150
Munsch, D., Watanabe-Fukunaga, R., Bourdon, J.-C., Nagata, S., May, E., Yonish-Rouach, E., & Reisdorf, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3867 · Cited by 131
Human p53 Is Phosphorylated on Serines 6 and 9 in Response to DNA Damage-inducing Agents
Higashimoto, Y., Saito, S., Tong, X.-H., Hong, A., Sakaguchi, K., Appella, E., & Anderson, C. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002674200 · Cited by 128
Fontemaggi, G., Gurtner, A., Strano, S., Higashi, Y., Sacchi, A., Piaggio, G., & Blandino, G. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8461-8470.2001 · Cited by 138
Nevels, M. M., Rubenwolf, S., Spruß, T., Wolf, H. J., & Dobner, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1206 · Cited by 124
p53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
An induced fit mechanism regulates p53 DNA binding kinetics to confer sequence specificity
Petty, T. J., Emamzadah, S., Costantino, L., Petkova, I., Stavridi, E. S., Saven, J. G., Vauthey, E., & Halazonetis, T. D. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.127 · Cited by 117
Demma, M., Maxwell, E., Ramos, R., Liang, L., Li, C., Hesk, D., Rossman, R., Mallams, A., Doll, R., Liu, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.083469 · Cited by 107
Nagata, Y., Anan, T., Yoshida, T., Mizukami, T., Taya, Y., Fujiwara, T., Kato, H., Saya, H., & Nakao, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202978 · Cited by 108
Tumour suppressors: A developing role for p53?
Hall, P. A., & Lane, D. P. (1997) · Current Biology · doi:10.1016/s0960-9822(97)70074-5 · Cited by 101
Dynamic interactions of p53 with DNA in solution by time-lapse atomic force microscopy
Jiao, Y., Cherny, D. I., Heim, G., Jovin, T. M., & Schäffer, T. E. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5129 · Cited by 95
Strano, S., Rossi, M., Fontemaggi, G., Munarriz, E., Soddu, S., Sacchi, A., & Blandino, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02119-6 · Cited by 88
Park, J., Seo, T., Hwang, S., Lee, D., Gwack, Y., & Choe, J. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11977-11982.2000 · Cited by 87
Effect of Zn2+ on DNA Recognition and Stability of the p53 DNA-Binding Domain
Duan, J., & Nilsson, L. (2006) · Biochemistry · doi:10.1021/bi0603165 · Cited by 80
Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients
Alsner, J., Yilmaz, M. K., Guldberg, P., Hansen, L. L., & Overgaard, J. (2000) · Breast Cancer Research · doi:10.1186/bcr109 · Cited by 79
Structure and functionality of a designed p53 dimer11Edited by P. E. Wright
Davison, T. S., Nie, X., Ma, W., Lin, Y., Kay, C. M., Benchimol, S., & Arrowsmith, C. H. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4450 · Cited by 89
Tumour p53 mutations exhibit promoter selective dominance over wild type p53
Monti, P., Campomenosi, P., Ciribilli, Y., Iannone, R., Inga, A., Abbondandolo, A., Resnick, M. A., & Fronza, G. (2002) · Oncogene · doi:10.1038/sj.onc.1205250 · Cited by 77
Mateu, M. G., & Fersht, A. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3595 · Cited by 72
Detection of the p53 response in zebrafish embryos using new monoclonal antibodies
Lee, K.-C., Goh, W. L., Xu, M., Kua, N., Lunny, D. P., Wong, J. S., Coomber, D., Vojtĕsek, B., Lane, E. B., & Lane, D. P. (2007) · Oncogene · doi:10.1038/sj.onc.1210695 · Cited by 73
Klein, C., Georges, G., Künkele, K.-P., Huber, R., Engh, R. A., & Hansen, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103801200 · Cited by 71
Mittl, P. R. E., Chène, P., & Grütter, M. G. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444997006550 · Cited by 69
Mutation Hotspots and DNA Methylation
Pfeifer, G. P., Tang, M.-S., & Denissenko, M. F. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59696-4_1 · Cited by 79
p53–RNA interactions: New clues in an old mystery
Riley, K. J.-L., & Maher, L. J. (2007) · RNA · doi:10.1261/rna.673407 · Cited by 78
Morphological changes in the testis after long-term valproate treatment in male Wistar rats
Røste, L. S., Taubøll, E., Berner, A., Berg, K. A., Aleksandersen, M., & Gjerstad, L. (2001) · Seizure · doi:10.1053/seiz.2001.0545 · Cited by 67
p63 and p73: old members of a new family
Marín, M. C., & Kaelin, W. G. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00010-x · Cited by 75
Structural and Drug Targeting Insights on Mutant p53
Gomes, A. S., Ramos, H., Inga, A., Sousa, E., & Saraiva, L. (2021) · Cancers · doi:10.3390/cancers13133344 · Cited by 62
Formation and repair of DNA lesions in thep53 gene: Relation to cancer mutations?
Pfeifer, G. P., & Denissenko, M. F. (1998) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1998)31:3<197::aid-em1>3.0.co;2-i · Cited by 76
Augustin, M., Bamberger, C., Paul, D., & Schmale, H. (1998) · Mammalian Genome · doi:10.1007/s003359900891 · Cited by 63
Paleček, E., Brázdová, M., Černocká, H., Vlk, D., Brázda, V., & Vojtěšek, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202710 · Cited by 62
Origins and selection of p53 mutations in lung carcinogenesis
Rodin, S. N., & Rodin, A. S. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.08.005 · Cited by 70
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 64
Inga, A., Monti, P., Fronza, G., Darden, T., & Resnick, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204116 · Cited by 64
Liang, S., & Clarke, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202350 · Cited by 65
Inga, A., & Resnick, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204457 · Cited by 63
Liang, S., Hong, D., & Clarke, M. F. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.31.19817 · Cited by 60
Aga, S. S., Shah, Z. A., Syeed, N., Banday, M. Z., Bashir, S. M., Bhat, B. A., & Siddiqi, M. A. (2010) · Genetics and Molecular Research · doi:10.4238/vol9-2gmr751 · Cited by 53
Fish p53 as a possible biomarker for genotoxins in the aquatic environment
Bhaskaran, A., May, D., Rand‐Weaver, M., & Tyler, C. R. (1999) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1999)33:3<177::aid-em1>3.0.co;2-x · Cited by 51
Cat Mammary Tumors: Genetic Models for the Human Counterpart
Adega, F., Borges, A., & Chaves, R. (2016) · Veterinary Sciences · doi:10.3390/vetsci3030017 · Cited by 57
Pinto, G. R., Yoshioka, F. K. N., da Silva, R. L. L., Clara, C., dos Santos, M. J., Almeida, J. R. W., Burbano, R. M. R., REY, J. A., & Casartelli, C. (2008) · Genetics and Molecular Research · doi:10.4238/vol7-1gmr415 · Cited by 52
Monti, P., Campomenosi, P., Ciribilli, Y., Iannone, R., Aprile, A., Inga, A., Tada, M., Menichini, P., Abbondandolo, A., & Fronza, G. (2003) · Oncogene · doi:10.1038/sj.onc.1206511 · Cited by 52
Sedláček, Z., Kodet, R., Kriz, V., Seemanová, E., Vodvarka, P., Wilgenbus, P., Mareš, J., Poustka, A. J., & Goetz, P. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.172 · Cited by 48
Brzuzan, P., Woźny, M., Ciesielski, S., Łuczyński, M. K., Góra, M., Kuźmiński, H., & Dobosz, S. (2009) · Toxicon · doi:10.1016/j.toxicon.2009.03.032 · Cited by 51
Cherny, D. I., Striker, G., Subramaniam, V., Jett, S. D., Paleček, E., & Jovin, T. M. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3299 · Cited by 47
High variability and non-neutral evolution of the mammalian avpr1a gene
Fink, S., Excoffier, L., & Heckel, G. (2007) · BMC Evolutionary Biology · doi:10.1186/1471-2148-7-176 · Cited by 53
Vogl, F. D., Frey, M., Kreienberg, R., & Runnebaum, I. B. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1446 · Cited by 46
The ‘wildtype’ conformation of p53: epitope mapping using hybrid proteins
Wang, P. L., Sait, F., & Winter, G. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204316 · Cited by 46
Effect of p53 Protein Redox States on Binding to Supercoiled and Linear DNA
Fojta, M., Kubičárová, T., Vojtěšek, B., & Paleček, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25749 · Cited by 45
Presence of p53 mutations in feline neoplasms
Mayr, B., BLAUENSTEINER, J., EDLINGER, A., Reifinger, M., Alton, K., Schaffner, G., & Brem, G. (2000) · Research in Veterinary Science · doi:10.1053/rvsc.1999.0339 · Cited by 44
Zhao, Y., Ren, J., Wang, M., Zhang, S.-T., Liu, Y., Li, M., Cao, Y.-B., Zu, H.-Y., Chen, X., Wu, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320369110 · Cited by 44
Identification and phylogenetic comparison of p53 in two distinct mussel species (Mytilus)
Muttray, A. F., Cox, R. L., St-Jean, S. D., van Poppelen, P., Reinisch, C. L., & Baldwin, S. A. (2005) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cca.2005.02.011 · Cited by 52
McKendrick, L., Milne, D., & Meek, D. W. (1999) · Springer eBooks · doi:10.1007/978-1-4419-8624-5_23 · Cited by 42
Jett, S. D., Cherny, D. I., Subramaniam, V., & Jovin, T. M. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3759 · Cited by 41
p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
Rius‐Pérez, S. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.07.022 · Cited by 40
Bensaad, K., Le Bras, M., Unsal, K., Strano, S., Blandino, G., Tominaga, O., Rouillard, D., & Soussi, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208233200 · Cited by 34
Self-citationEnergetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding
Li, Z., Yan, J., Matheny, C., Corpora, T., Bravo, J., Warren, A. J., Bushweller, J. H., & Speck, N. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303973200 · Cited by 41
McKendrick, L., Milne, D., & Meek, D. W. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006854109926 · Cited by 39
Recommendations for Analyzing and ReportingTP53Gene Variants in the High-Throughput Sequencing Era
Soussi, T., Leroy, B., & Taschner, P. E. M. (2014) · Human Mutation · doi:10.1002/humu.22561 · Cited by 40
Self-citationDephosphorylation of p53 at Ser20 after cellular exposure to low levels of non-ionizing radiation
Craig, A. L., Blaydes, J. P., Burch, L. R., Thompson, A. M., & Hupp, T. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203085 · Cited by 37
Solution conformation of an essential region of the p53 transactivation domain
Botuyan, M. V., Momand, J. A., & Chen, Y. (1997) · Folding and Design · doi:10.1016/s1359-0278(97)00047-3 · Cited by 37
Anderson, C. W., & Allalunis‐Turner, M. J. (2000) · Radiation Research · doi:10.1667/0033-7587(2000)154[0473:htftmg]2.0.co;2 · Cited by 39
Regulation of p53 mediated transactivation by the β‐subunit of protein kinase CK2
Schuster, N., Prowald, A., Schneider, E., Scheidtmann, K., & Montenarh, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00273-2 · Cited by 39
Hansen, S., Lane, D. P., & Midgley, C. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1507 · Cited by 41
Farcy, É., Fleury, C., Lelong, C., Dubos, M., Voiseux, C., Fiévet, B., & Lebel, J. (2008) · Marine Environmental Research · doi:10.1016/j.marenvres.2008.04.006 · Cited by 36
New developments in the multi-site phosphorylation and integration of stress signalling at p53
Meek, D. W. (1998) · International Journal of Radiation Biology · doi:10.1080/095530098141005 · Cited by 38
Regulation of the DNA binding of p53 by its interaction with protein kinase CK2
Prowald, A., Schuster, N., & Montenarh, M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00399-2 · Cited by 36
Mechanistic insights into p53-promoted RNA-RNA annealing
Nedbal, W., Frey, M., Willemann, B., Zentgraf, H., & Sczakiel, G. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0813 · Cited by 37
Protein kinase CK2 interacts with a multi-protein binding domain of p53
Götz, C., Scholtes, P., Prowald, A., Schuster, N., Nastainczyk, W., & Montenarh, M. (1999) · Springer eBooks · doi:10.1007/978-1-4419-8624-5_14 · Cited by 33
Jamonnak, N., Hirsch, B. M., Pang, Y., & Zheng, W. (2009) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2009.10.001 · Cited by 35
Neel, H., Daujat, S., Piette, J., Thisse, C., & Thisse, B. (2000) · Differentiation · doi:10.1046/j.1432-0436.2000.660201.x · Cited by 37
Lee, Y., Rhee, J., Hwang, D., Kim, I., Raisuddin, S., & Lee, J. (2007) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2007.09.005 · Cited by 30
Lamolle, G., Marín, M., & Álvarez-Valín, F. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.03.004 · Cited by 35
A novel p53 mutant retained functional activity in lung carcinomas
Ko, J., Chiao, M.-C., Chang, S.-L., Lin, P., Lin, J.-C., Gwo-Tarng, S., & Lee, H. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00094-0 · Cited by 31
The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells
Kim, H., You, S., Foster, L. K., Farris, J., & Foster, D. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204664 · Cited by 28
Protein kinase CK2 interacts with a multi-protein binding domain of p53
Götz, C., Scholtes, P., Prowald, A., Schuster, N., Nastainczyk, W., & Montenarh, M. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006886727248 · Cited by 38
Røste, L. S., Taubøll, E., Isojärvi, J. I. T., Berner, A., Berg, K. A., Pakarinen, A., Huhtaniemi, I. T., Knip, M., & Gjerstad, L. (2003) · Seizure · doi:10.1016/s1059-1311(03)00056-6 · Cited by 29
In vitro evolution of thermostable p53 variants
Matsumura, I., & Ellington, A. D. (1999) · Protein Science · doi:10.1110/ps.8.4.731 · Cited by 27
Pandith, A. A., Shah, Z. A., Khan, N. P., Rasool, R., Afroze, D., Yousuf, A., Wani, S., & Siddiqi, M. A. (2010) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2010.08.010 · Cited by 27
Redox Sensitive Cysteine Residues as Crucial Regulators of Wild-Type and Mutant p53 Isoforms
Butturini, E., Butera, G., Pacchiana, R., de Prati, A. C., Mariotto, S., & Donadelli, M. (2021) · Cells · doi:10.3390/cells10113149 · Cited by 28
Metadata
- Authors
- Soussi, T., & May, P.
- Affiliations
- Inserm (FR)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- Corresponding author
- Soussi, Thierry
- ORCID
- Soussi, Thierry
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 1996-08
- Volume
- 260
- Issue
- 5
- Pages
- 623-637
- ISSN
- 0022-2836 (ISSN-L)
- OpenAlex
- W2012183441
- Cited by
- 208
- References
- 141
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 6 · 2020: 1 · 2018: 4 · 2016: 3 · 2015: 6 · 2014: 5 · 2013: 7 · 2012: 1
- FWCI
- 13.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Journal of Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ligue Contre le Cancer
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, protein structure, gene evolution, protein flexibility, protein sequence comparison, crystallography, protein function, tumor suppressor
- MeSH terms
- Amino Acid Sequence, Animals, Base Sequence, Cricetinae, Molecular Sequence Data, Phylogeny, Protein Conformation, Structure-Activity Relationship, Genes, p53, Tumor Suppressor Protein p53, Conserved Sequence, Sequence Homology, Amino Acid, Protein Structure, Tertiary, Evolution, Molecular
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.